Kenneth W. Wyman, M.D.

Assistant Professor

ken.wyman@vanderbilt.edu
Faculty Appointments
Assistant Professor of Medicine
Education
M.D., medicine, University of Louisville, Louisville, KentuckyB.S., Biology, Murray State University, Murray, Kentucky
Office Address
Vanderbilt-Ingram Cancer Center
777 Preston Research Building
Nashville, TN 7602
Publications
Wyman K, Atkins MB, Prieto V, Eton O, McDermott DF, Hubbard F, Byrnes C, Sanders K, Sosman JA. Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy. Cancer. 2006 May 5/1/2006; 106(9): 2005-11. PMID: 16565971, DOI: 10.1002/cncr.21834, ISSN: 0008-543X.

Tedesco KL, Berlin J, Rothenberg M, Choy H, Wyman K, Scott Pearson A, Daniel Beauchamp R, Merchant N, Lockhart AC, Shyr Y, Caillouette C, Chakravarthy B. A phase I study of concurrent 9-nitro-20(s)-camptothecin (9NC/Orathecin) and radiation therapy in the treatment of locally advanced adenocarcinoma of the pancreas. Radiother Oncol. 2005 Jul; 76(1): 54-8. PMID: 15921772, PII: S0167-8140(05)00169-6, DOI: 10.1016/j.radonc.2005.04.005, ISSN: 0167-8140.

Tedesco KL, Berlin J, Blanke CD, Teng M, Choy H, Roberts J, Beauchamp RD, Leach S, Wyman K, Tarpley J, Shyr Y, Caillouette C, Chakravarthy B. Phase I trial of Orzel (UFT plus leucovorin), cisplatin, and radiotherapy in the treatment of potentially resectable esophageal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2005 Apr 4/1/2005; 61(5): 1364-70. PMID: 15817338, PII: S0360-3016(04)02471-X, DOI: 10.1016/j.ijrobp.2004.08.050, ISSN: 0360-3016.